Product Images Atorvastatin Calcium

The text appears to be a figure caption from a medical or scientific study involving atorvastatin calcium. It describes the effect of a 10 mg daily dose of this drug on the cumulative incidence of non-fatal myocardial infarction or coronary heart disease death over a period of up to 35 years. The graph in Figure 1 shows a cumulative incidence percentage of 40 at the start of the study, with a decrease in incidence over time. The hazard ratio (HR) for this effect is reported as 0.64, with a confidence interval of (0.50-0.83) and a p-value of 0.0005. It is difficult to interpret this information without additional context or knowledge of the study.*

The text describes the effect of Atorvastatin Calcium 10 mg/day on the time it takes for a major cardiovascular event (including myocardial infarction, acute coronary heart disease death, unstable angina, coronary revascularization, or stroke) to occur in a study called CARDS. The figure shows a graph of the cumulative hazard over time, with a hazard ratio and p-value displayed.*

This is a figure showing the effect of Atorvastatin Calcium at a dosage of 80 mg/day versus 10 mg/day on the time it takes for major cardiovascular events to occur. The percentages of subjects experiencing the event are graphed over time, with years on the x-axis and the percentage on the y-axis. The figure also includes a hazard ratio (HR) of 0.78 with a 95% confidence interval (0.69-0.89) and a p-value of 0.0002.*

Atorvastatin Calcium Tablets, USP are film-coated tablets that contain 20 mg of atorvastatin calcium. This medication is intended for adult use only and should be kept out of reach of children. It should be stored in a tight, child-resistant container at room temperature (20°C to 25°C). The tablets come in a 90-count bottle and are distributed by NILD Pharmaceuticals. The NDC number for this medication is 63629-8471-1. This medication requires a prescription.*